Argent BioPharma Limited logo

Argent BioPharma Limited (RGT)

Market Open
ASX ASX
3.39M Market Cap
- P/E Ratio
- Div Yield
16,857 Volume
- Eps
Want to track RGT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
26 Feb 2026
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
3 Dec 2025
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
28 Aug 2025
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
27 Jul 2025
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
26 Feb 2025
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
29 Nov 2024
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
30 Sep 2024
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
30 Aug 2024
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
26 Jul 2024
-
-
Argent BioPharma Limited logo
RGT Argent BioPharma Limited
30 Apr 2024
-
-

RGT Earnings Reports FAQ

What is the earnings per share (EPS) for RGT?

EPS data for RGT is currently not available, as Argent BioPharma Limited has not reported recent earnings.

What is the company's earnings growth rate?

Argent BioPharma Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Argent BioPharma Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Argent BioPharma Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for RGT at this time, as Argent BioPharma Limited has no recent EPS data to calculate it.